Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | V |
| Molecular Weight | 50.9415 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[V]
InChI
InChIKey=LEONUFNNVUYDNQ-UHFFFAOYSA-N
InChI=1S/V
DescriptionCurator's Comment: description was created based on several sources, including
http://www.hmdb.ca/metabolites/HMDB02503 | https://www.ncbi.nlm.nih.gov/mesh/68014639 | https://www.ncbi.nlm.nih.gov/pubmed/12050018
Curator's Comment: description was created based on several sources, including
http://www.hmdb.ca/metabolites/HMDB02503 | https://www.ncbi.nlm.nih.gov/mesh/68014639 | https://www.ncbi.nlm.nih.gov/pubmed/12050018
Vanadium (V) is a steel-grey, corrosion-resistant metal. Because of its hardness and its ability to form alloys, vanadium (i.e., ferrovanadium) is a common component of hard steel alloys used in machines and tools. Although most foods contain low concentrations of vanadium (< 1 ng/g), food is the major source of exposure to vanadium for the general population. Vanadium is probably an essential trace element, but a vanadium-deficiency disease has not been identified in humans. At pharmacological doses, vanadium compounds display relevant biological actions such as mimicking insulin and growth factors as well as having osteogenic activity. Some vanadium compounds also show antitumoral properties.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Inhibitory effect of vanadium on rat liver carcinogenesis initiated with diethylnitrosamine and promoted by phenobarbital. | 1995 Jun |
|
| Cytokine production by human airway epithelial cells after exposure to an air pollution particle is metal-dependent. | 1997 Oct |
|
| Pulmonary responses to oil fly ash particles in the rat differ by virtue of their specific soluble metals. | 1998 Jun |
|
| Lung mucin production is stimulated by the air pollutant residual oil fly ash. | 2000 Jan 15 |
|
| Differential ability of transition metals to induce pulmonary inflammation. | 2001 Nov 15 |
|
| Novel vanadium-binding proteins (vanabins) identified in cDNA libraries and the genome of the ascidian Ciona intestinalis. | 2003 Nov 30 |
|
| Vanadium--an element of atypical biological significance. | 2004 Apr 21 |
|
| Activation of aPKC is required for vanadate-induced phosphorylation of protein kinase B (Akt), but not p70S6k in mouse epidermal JB6 cells. | 2004 Jan |
|
| Pollutant particles produce vasoconstriction and enhance MAPK signaling via angiotensin type I receptor. | 2005 Aug |
|
| [Regulatory effects of micronutrient complex on the expression of Th1 and Th2 cytokines in diabetic C57BL mice]. | 2005 Jan |
|
| Vanadium induces apoptosis and modulates the expressions of metallothionein, Ki-67 nuclear antigen, and p53 during 2-acetylaminofluorene-induced rat liver preneoplasia. | 2005 Mar 1 |
|
| Protective role of vanadium on the early process of rat mammary carcinogenesis by influencing expression of metallothionein, GGT-positive foci and DNA fragmentation. | 2005 Nov-Dec |
|
| Divalent metal transporter-1 decreases metal-related injury in the lung. | 2005 Sep |
|
| Oral vanadium enhances the catabolic effects of central leptin in young adult rats. | 2006 Jan |
|
| Vanadium and insulin increase adiponectin production in 3T3-L1 adipocytes. | 2006 Jul |
|
| Effects of 12 metal ions on iron regulatory protein 1 (IRP-1) and hypoxia-inducible factor-1 alpha (HIF-1alpha) and HIF-regulated genes. | 2006 Jun 15 |
|
| Effects of select PM-associated metals on alveolar macrophage phosphorylated ERK1 and -2 and iNOS expression during ongoing alteration in iron homeostasis. | 2006 May |
|
| Vanadium inhibits the development of 2-acetylaminofluorene-induced premalignant phenotype in a two-stage chemical rat hepatocarcinogenesis model. | 2006 May 8 |
|
| Upregulation of LITAF mRNA expression upon exposure to TiAlV and polyethylene wear particles in THP-1 macrophages. | 2007 Apr |
|
| Protective effects of vanadium against DMH-induced genotoxicity and carcinogenesis in rat colon: removal of O(6)-methylguanine DNA adducts, p53 expression, inducible nitric oxide synthase downregulation and apoptotic induction. | 2008 Feb 29 |
|
| Source apportionment of particulate matter in the U.S. and associations with lung inflammatory markers. | 2008 May |
|
| Down-regulation of the carcinogen-metabolizing enzyme cytochrome P450 1a1 by vanadium. | 2008 Sep |
|
| Endothelial effects of emission source particles: acute toxic response gene expression profiles. | 2009 Feb |
|
| Protective effects of combined micronutrients on islet beta-cells of streptozotocin-induced diabetic mice. | 2009 Mar |
|
| Modulation of cytochrome P450 1 (Cyp1) by vanadium in hepatic tissue and isolated hepatocyte of C57BL/6 mice. | 2013 Aug |
Patents
Sample Use Guides
Tolerable upper intake level for adults is 1.8 mg/day.
Route of Administration:
Oral
Vanadate (V) ions competitively inhibit calf thymus terminal deoxynucleotidyl transferase with Ki = 2.5 microM. A binding of vanadium to the enzyme with no change of the amount of the Zn constituent of the protein was found at concentrations of vanadate causing inhibition. The catalytic activity of mammalian DNA polymerase alpha was also inhibited by vanadate ions at an I50 of 60 microM, while the bacterial (E. coli) DNA polymerase I was affected to the same extent only when the concentration of vanadate was raised to about 0.5 mM. In contrast to the inhibitory effects caused by vanadium on the nucleotidyl transferases, concentrations of pentavalent vanadium ions of the order of 10 microM increase 2.4-fold the hydrolytic activity of deoxyribonuclease I from bovine pancreas.
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
DSLD |
132 (Number of products:1869)
Created by
admin on Fri Dec 15 16:46:38 GMT 2023 , Edited by admin on Fri Dec 15 16:46:38 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
7440-62-2
Created by
admin on Fri Dec 15 16:46:38 GMT 2023 , Edited by admin on Fri Dec 15 16:46:38 GMT 2023
|
PRIMARY | |||
|
DB13971
Created by
admin on Fri Dec 15 16:46:38 GMT 2023 , Edited by admin on Fri Dec 15 16:46:38 GMT 2023
|
PRIMARY | |||
|
m11374
Created by
admin on Fri Dec 15 16:46:38 GMT 2023 , Edited by admin on Fri Dec 15 16:46:38 GMT 2023
|
PRIMARY | Merck Index | ||
|
231-171-1
Created by
admin on Fri Dec 15 16:46:38 GMT 2023 , Edited by admin on Fri Dec 15 16:46:38 GMT 2023
|
PRIMARY | |||
|
1022
Created by
admin on Fri Dec 15 16:46:38 GMT 2023 , Edited by admin on Fri Dec 15 16:46:38 GMT 2023
|
PRIMARY | |||
|
27698
Created by
admin on Fri Dec 15 16:46:38 GMT 2023 , Edited by admin on Fri Dec 15 16:46:38 GMT 2023
|
PRIMARY | |||
|
D014639
Created by
admin on Fri Dec 15 16:46:38 GMT 2023 , Edited by admin on Fri Dec 15 16:46:38 GMT 2023
|
PRIMARY | |||
|
C68292
Created by
admin on Fri Dec 15 16:46:38 GMT 2023 , Edited by admin on Fri Dec 15 16:46:38 GMT 2023
|
PRIMARY | |||
|
00J9J9XKDE
Created by
admin on Fri Dec 15 16:46:38 GMT 2023 , Edited by admin on Fri Dec 15 16:46:38 GMT 2023
|
PRIMARY | |||
|
11121
Created by
admin on Fri Dec 15 16:46:38 GMT 2023 , Edited by admin on Fri Dec 15 16:46:38 GMT 2023
|
PRIMARY | RxNorm | ||
|
23990
Created by
admin on Fri Dec 15 16:46:38 GMT 2023 , Edited by admin on Fri Dec 15 16:46:38 GMT 2023
|
PRIMARY | |||
|
00J9J9XKDE
Created by
admin on Fri Dec 15 16:46:38 GMT 2023 , Edited by admin on Fri Dec 15 16:46:38 GMT 2023
|
PRIMARY | |||
|
35170
Created by
admin on Fri Dec 15 16:46:38 GMT 2023 , Edited by admin on Fri Dec 15 16:46:38 GMT 2023
|
PRIMARY | |||
|
DTXSID2040282
Created by
admin on Fri Dec 15 16:46:38 GMT 2023 , Edited by admin on Fri Dec 15 16:46:38 GMT 2023
|
PRIMARY | |||
|
SUB37143
Created by
admin on Fri Dec 15 16:46:38 GMT 2023 , Edited by admin on Fri Dec 15 16:46:38 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
